SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-22-005298
Filing Date
2022-08-03
Accepted
2022-08-03 16:43:14
Documents
44
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sunshinebio_i10q-063022.htm   iXBRL 10-Q 466349
2 CERTIFICATION sunshinebio_ex3101.htm EX-31.1 10359
3 CERTIFICATION sunshinebio_ex3102.htm EX-31.2 10344
4 CERTIFICATION sunshinebio_ex3201.htm EX-32.1 4341
5 GRAPHIC image_001.gif GRAPHIC 4944
6 GRAPHIC image_002.gif GRAPHIC 8466
7 GRAPHIC image_001.jpg GRAPHIC 27733
  Complete submission text file 0001683168-22-005298.txt   2551477

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE sbfm-20220630.xsd EX-101.SCH 21267
9 XBRL CALCULATION FILE sbfm-20220630_cal.xml EX-101.CAL 36059
10 XBRL DEFINITION FILE sbfm-20220630_def.xml EX-101.DEF 108785
11 XBRL LABEL FILE sbfm-20220630_lab.xml EX-101.LAB 169640
12 XBRL PRESENTATION FILE sbfm-20220630_pre.xml EX-101.PRE 151694
38 EXTRACTED XBRL INSTANCE DOCUMENT sunshinebio_i10q-063022_htm.xml XML 220474
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41282 | Film No.: 221133295
SIC: 8731 Services-Commercial Physical & Biological Research